Scientists said that they left the door at least slightly open to similar drugs in development from Merck and Roche, which are called CETP inhibitors.

• 科学家说，他们离开的大门，至少稍微开放，以类似药物的发展，由默克公司和罗氏公司，这是所谓的胆固醇酯转运蛋白抑制剂。